MIMS Summary: HPV vaccine recommended for immunisation programme

The government has announced the introduction of a human papilloma virus (HPV) immunisation programme starting in September 2008.

The programme will involve the routine vaccination of girls aged 12–13 years against cervical cancer. There will also be a two-year catch-up campaign, starting in Autumn 2009, for girls aged up to 18 years.

Currently in England there are about 2,200 cases of cervical cancer a year, with about 800 deaths. HPV causes 99 per cent of invasive cervical cancer, and it is estimated that HPV vaccines could reduce the number of cases by 70 per cent.

The routine HPV immunisation programme could cost up to £100m a year and the catch-up programme may cost up to £200m in 2009/10 and 2010/11, but the Department of Health (DoH) aims to negotiate a reduction in the vaccine price during the procurement process.

Primary care trusts will plan how to deliver the vaccination programme locally. However, the Joint Committee on Vaccination and Immunisation (JCVI) has advised that HPV vaccination would be most efficiently delivered through schools.

Implementing the programme will be complex, as three doses of the vaccine are required to provide protection.
Currently, two licensed HPV vaccines are available, Gardasil and Cervarix; however, no decision has been made on which of the two vaccines will be used.

Following advice from the JCVI, the cervical screening programme will continue after the HPV vaccination programme has been introduced. This is necessary because the vaccine does not protect against all HPV types that may cause cervical cancer.

The JCVI carried out a detailed review of the evidence surrounding HPV vaccination before presenting the following:

  • Routine vaccination of girls aged around 12–13 years is recommended.
  • Catch-up programme for girls under the age of 18 years is recommended.
  • There is evidencethat a catch-up programme for all women aged 18–25 years was unlikely to be cost effective but could benefit some individual women; the DoH will consider this further.

Further information on the HPV vaccination programme and the JCVI recommendations is available at www.dh.gov.uk.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...

Medeconomics Live aims to help practices thrive under the new GP contract

Medeconomics Live aims to help practices thrive under the new GP contract

The one-day, virtual Medeconomics Live conference aims to provide practices with...

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GP practices have faced a wave of abuse and complaints after a letter from NHS England...

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

The government has denied plans to make GPs 'gatekeepers' of the struggling COVID-19...